|1.||Kobayashi, Toshihide: 3 articles (02/2007 - 01/2004)|
|2.||Umezawa, Kazuo: 2 articles (08/2013 - 06/2012)|
|3.||Sukumwang, Neelanun: 2 articles (08/2013 - 06/2012)|
|4.||Ishitsuka, Reiko: 2 articles (02/2007 - 01/2004)|
|5.||Makino, Asami: 2 articles (08/2004 - 01/2004)|
|6.||Yamaji-Hasegawa, Akiko: 2 articles (08/2004 - 01/2004)|
|7.||Simizu, Siro: 1 article (06/2012)|
|8.||Ikeda, Yoko: 1 article (06/2012)|
|9.||Kovitayakorn, Taworn: 1 article (06/2012)|
|10.||Matsui, Chino: 1 article (06/2012)|
06/01/2012 - "In the present study, we screened for inhibitors of lysenin-induced hemolysis by using an optimized screening system and found a methanolic extract of Dalbergia latifolia leaves to be a potential candidate. "
06/01/2012 - "Although the mechanism of lysenin-induced hemolysis is unique, its precise mechanism of action and its inhibitors are poorly understood. "
01/01/2004 - "After binding to the cell membranes of target cells, lysenin forms oligomers in an SM-dependent manner, with subsequent formation of pores with a hydrodynamic diameter of approximately 3?nm. The biochemical interactions between lysenin and SM in cell membranes are responsible for the pharmacological activities of lysenin and of CF that contains lysenin in vertebrates, such as hemolysis, cytotoxicity, and contraction of smooth muscle in vitro and vasodepressor activity and lethality in vivo. "
02/13/2007 - "In the present study, we examined the effects of the presence of cholesterol in the SM membrane on the inhibition of hemolysis, the binding of lysenin to SM, and the oligomerization of lysenin. "
08/01/2013 - "Additionally, we isolated tyrosylproline anhydride from the culture filtrate of Streptomyces as an inhibitor of Lysenin-induced hemolysis. "
|2.||Type A Niemann-Pick Disease
|3.||Melanoma (Melanoma, Malignant)
|3.||LDL-Receptor Related Protein 2